FindMyKOL
Clinical trialNCT00125099CompletedPhase 1/PHASE2Interventional

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment21HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate whether the HIV vaccine VRC-HIVDNA009-00-VP will be safe in individuals who started antiretroviral therapy during acute HIV-1 infection. The study will also test whether the vaccine can increase the immune system function in these participants.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Dan H. Barouch, MD, PhD

    Beth Israel Deaconess Medical Center, Division of Viral Pathogenesis

    Study Chair
    clinicaltrials.gov ↗
  • Eric S. Rosenberg, MD

    Massachusetts General Hospital, Division of Infectious Diseases

    Study Chair
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsd, Avrc Crs

    San Diego, California, United States

  • Brigham and Women'S Hosp. Actg Crs

    Boston, Massachusetts, United States

  • Massachusetts General Hospital Actg Crs

    Boston, Massachusetts, United States

  • Aaron Diamond Aids Research Ctr. Aiedrp

    New York, New York, United States

  • Uw Primary Infection Clinic Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

VRC-HIVDNA009-00-VP
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
30 Sept 2007
Last update posted
1 Nov 2021
Registered enrollment
21
Registry id
NCT00125099
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.